Results 101 to 110 of about 9,825 (155)

Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection. [PDF]

Pharmaceuticals (Basel)
Dybowska D, Pawłowska M, Kozielewicz D.
europepmc   +1 more source

Histopathological features and eight-week split-tablet sofosbuvir/velpatasvir treatment in young children with acute hepatitis C: a case-series study. [PDF]

BMC Infect Dis
Pan YJ, Chen RY, Ai YQ, Zeng QL.
europepmc   +1 more source

An in-hospital referral program for hepatitis C virus elimination in patients with type 2 diabetes mellitus. [PDF]

J Chin Med Assoc
Chi CT, Wu TH, Lee PC, Su GY, Chen TY, Lee IC, Hou MC, Hwu CM, Huang YH.   +8 more
europepmc   +1 more source

In Silico Characterization of Two Human Pegivirus Proteins Highlights Similarities with Hepatitis C Virus and Possible Therapeutic Repurposing. [PDF]

Viruses
Copenhaver KM, Hanson BA, Ziarek JJ, Koralnik IJ.   +3 more
europepmc   +1 more source

Mechanism of SARS-CoV-2 resistance to nucleotide analog-based antivirals. [PDF]

Nat Commun
Liu C, Li Y, Cao X, Gleason RJ, Liu B, Yang Y.   +5 more
europepmc   +1 more source

Achieving Hepatitis C Micro-Elimination in a High-Burden Province of Thailand: The Phetchabun Model. [PDF]

Trop Med Infect Dis
Phaengkha W, Nilyanimit P, Suntronwong N, Puenpa J, Le DHH, Ngamnimit S, Janpathip P, Kamput L, Thongnoi K, Toomta W, Wohanklong P, Saokeaw J, Thammajit N, Rerngleum S, Yoisara A, Srisuk N, Suwannachat J, Karagate A, Wasitthankasem R, Poovorawan Y.   +19 more
europepmc   +1 more source

Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Teymourzadeh E, Salesi M, Keshavarz K, Abyazi MA, Heiat M, Alavian SM.   +7 more
europepmc   +1 more source

Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort. [PDF]

Sci Rep
Suda G, Baba M, Yamamoto Y, Yoshida S, Muranaka T, Meguro T, Terashita K, Ito J, Kobayashi T, Izumi T, Takagi T, Hosoda S, Yamada R, Fu Q, Yang Z, Yokoyama D, Tanaka T, Meno A, Yasuura N, Kitagataya T, Ohara M, Kawagishi N, Nakai M, Sho T, Ogawa K, Sakamoto N.   +25 more
europepmc   +1 more source

Identification of NS5B resistance-associated mutations in hepatitis C virus circulating in treatment-naïve Cameroonian patients. [PDF]

IJID Reg
Mounchili-Njifon A, Modiyinji AF, Mbouyap PR, Monamele CG, Moumbeket-Yifomnjou MH, Mfombouot PHN, Machuetum GL, Toueyem PI, Lissock SF, Tagnouokam-Ngoupo PA, Assam JPA, Njouom R.   +11 more
europepmc   +1 more source

Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan. [PDF]

J Viral Hepat
Shah S, Mafirakureva N, Trickey A, Hasnain A, Khan U, Khowaja S, Ashraf H, Baig-Ansari N, Hickman M, Vickerman P, Walker JG, Lim AG.   +11 more
europepmc   +1 more source